Clinical Trial Update: A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated pregabalin as add-on therapy in pediatric subjects under 4 with partial onset seizures; results completed with posted findings in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2018-10-09